Angiotensin-converting enzyme inhibitor dosages in elderly patients with heart failure

American Heart Journal

Volumn 141, Issue 3, 2001, Pages 410-417

  Chen, Ya Ting ^a   Wang, Yun ^b,c   Radford, Martha J ^a,b,c   Krumholz, Harlan M ^a,b,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE NEW HAVEN HOSPITAL   (United States)

^c QUALIDIGM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LISINOPRIL;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DATA BASE; DOSE RESPONSE; ELDERLY CARE; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 0035096993     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2001.113227     Document Type: Article

References (18)

1. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
2. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure
3. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
4. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Results of the Survival and Ventricular Enlargement Trial
5. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction
6. GISSI-3: Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction
7. Guidelines for the evaluation and management of heart failure: Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
8. Quality of care for elderly patients hospitalized with heart failure
9. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI)
10. Oral captopril versus placebo among 13634 patients with suspected acute myocardial infarction: Interim report from the Chinese Cardiac Study (CCS-1)
11. ISIS-4: A randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58050 patients with suspected acute myocardial infarction
12. Clinical outcome with enalapril in symptomatic chronic heart failure: A dose comparison
13. Assessment of treatment with lisinopril and survival (ATLAS)
14. Severity of heart failure and dosage of angiotensin converting enzyme inhibitors
15. Lack of relationship between the short-term hemodynamic effects of captopril and subsequent clinical responses
16. Renal function in severe congestive heart failure during treatment with enalapril (the Cooperative North Scandinavian Enalapril Survival Study [CONSENSUS] Trial)
17. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure